Category Filter

Category Filter

Drug Policies

Category Filter

Category Filter

Asset Publisher

Policy # Policy Title Print View
VP-0425 Asparlas® (calaspargase pegol-mknl)
VP-0426 Elzonris™ (tagraxofusp-erzs) (Intravenous)
VP-0449 Herceptin Hylecta™ (trastuzumab and hyaluronidase-oysk) (Subcutaneous)
VP-0482 Polivy™ (polatuzumab vedotin-piiq) (Intravenous)
VP-0503 Reblozyl® (luspatercept-aamt) (Subcutaneous)
VP-0521 Padcev™ (enfortumab vedotin-ejfv) (Intravenous)
VP-0522 Enhertu® (fam-trastuzumab deruxtecan-nxki) (Intravenous)
VP-0528 Sarclisa® (isatuximab-irfc) (Intravenous)
VP-0531 Jelmyto™ (mitomycin) (Intra-pyelocalyceal)
VP-0532 Trodelvy™ (sacituzumab govitecan-hziy) (Intravenous)
VP-0535 Darzalex Faspro™ (daratumumab and hyaluronidase-fihj) (Subcutaneous)
VP-0547 Evomela® (melphalan)
VP-0550 Zepzelca™ (lurbinectedin) (Intravenous)
VP-0553 Phesgo™ (pertuzumab, trastuzumab and hyaluronidase-zzxf) (Subcutaneous)
VP-0558 Tecartus™ (brexucabtagene autoleucel) (Intravenous)
VP-0559 Monjuvi™ (tafasitamab-cxix) (Intravenous)
VP-0581 Danyelza® (naxitamab-gqgk) (Intravenous)
VP-0583 Margenza™ (margetuximab-cmkb) (Intravenous)
VP-0590 Breyanzi® (lisocabtagene maraleucel) (Intravenous)
VP-0598 Abecma® (idecabtagene vicleucel) (Intravenous)
VP-0599 Jemperli® (dostarlimab-gxly)
VP-0600 Zynlonta™ (loncastuximab tesirine-lpyl) (Intravenous)
VP-0607 Rybrevant™ (amivantamab-vmjw) (Intravenous)
VP-0612 Rylaze® (asparaginase Erwinia chrysanthemi (recombinant)-rywn)
VP-0624 Tivdak™ (tisotumab vedotin-tftv) (Intravenous)
VP-0647 Fyarro™ (sirolimus albumin-bound) (Intravenous)
VP-0658 Kimmtrak® (tebentafusp-tebn) (Intravenous)
VP-0663 Carvykti™ (ciltacabtagene autoleucel) (Intravenous)
VP-0664 Opdualag™ (nivolumab/relatlimab-rmbw) (Intravenous)
VP-0679 Pedmark® (sodium thiosulfate) (Intravenous)
VP-0682 Tecvayli™ (teclistamab-cqyv) (Subcutaneous)
VP-0683 Imjudo® (tremelimumab-actl) (Intravenous)
VP-0686 Elahere™ (mirvetuximab soravtansine-gynx) (Intravenous)
VP-0691 Adstiladrin® (nadofaragene firadenovec-vncg) (Intravesical)
VP-0692 Lunsumio™ (mosunetuzumab-axgb) (Intravenous)
VP-0700 Zynyz™ (retifanlimab-dlwr)
VP-0707 Omisirge® (omidubicel-onlv)
VP-0710 Epkinly™ (epcoritamab-bysp)
VP-0711 Columvi™ (glofitamab-gxbm)
VP-0722 Talvey™ (talquetamab-tgvs)
VP-0724 Elrexfio™ (elranatamab-bcmm)
VP-0735 Loqtorzi™ (toripalimab-tpzi)
VP-0748 Amtagvi® (lifileucel)
VP-0750 Tevimbra™ (tislelizumab-jsgr)
VP-0753 Anktiva® (nogapendekin alfa inbakicept-pmln)
VP-0756 Imdelltra™ (tarlatamab-dlle) (Intravenous)
VP-0761 Rytelo® (imetelstat)
VP-0766 Lymphir™ (denileukin diftitox-cxdl)
VP-0775 Aucatzyl® (Obecabtagene Autoleucel - Obe-cel)
VP-0778 Ziihera® (zanidatamab-hrii)
VP-0779 Bizengri® (zenocutuzumab-zbco)
VP-0780 Unloxcyt® (cosibelimab-ipdl)
VP-0784 Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy)
VP-0785 Datroway® (datopotamab deruxtecan-dlnk)
VP-367 Elitek® (rasburicase) (Intravenous)